MetaCap

Galectin Therapeutics (GALT) News

NASDAQ: GALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.69-0.12 (-4.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GALT news summary

We found 2 recent headlines mentioning Galectin Therapeutics (GALT): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, GALT is down 4.27% at $2.69. The most recent story, "Galectin Therapeutics Inc. Reports September 30, 2026 Financial Results and $105.8 million Debt Conversion", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Galectin Therapeutics headlines

Compare GALT